Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |